ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $3.72B

      Shares

      34.7M

      % of Portfolio

      2.71%

      Average Buy Price

      $10.5

      Avg closing price
      Price range

      50 PRIMECAP Management Boston Scientific Trades

      PRIMECAP Management's position in Boston Scientific is currently worth $3.72B. That's 2.71% of their equity portfolio (7th largest holding). The investor owns 2.38% of the outstanding Boston Scientific stock. The first Boston Scientific trade was made in Q1 2013. Since then PRIMECAP Management bought shares fifteen more times and sold shares on 34 occasions. The stake costed the investor $363M, netting the investor a gain of 925% so far.

      Avg closing price
      Price range
      Sold 5.0% shares (-1.83M shares) Q2 2025
      Avg closing price $101.14
      Price range $89.70 - $107.41
      Sold 1.2% shares (-433k shares) Q1 2025
      Avg closing price $100.67
      Price range $89.38 - $106.18
      Sold 2.4% shares (-897k shares) Q4 2024
      Avg closing price $88.16
      Price range $83.62 - $91.51
      Sold 0.3% shares (-133k shares) Q3 2024
      Avg closing price $78.83
      Price range $72.96 - $84.00
      Increased shares by 0.0% (+11.4k shares) Q2 2024
      Avg closing price $73.20
      Price range $67.33 - $77.71
      Increased shares by 0.1% (+42k shares) Q1 2024
      Avg closing price $64.30
      Price range $57.60 - $68.62
      Increased shares by 1.5% (+550k shares) Q4 2023
      Avg closing price $53.38
      Price range $48.64 - $57.81
      Sold 0.2% shares (-73.8k shares) Q3 2023
      Avg closing price $52.45
      Price range $50.19 - $54.68
      Sold 2.3% shares (-899k shares) Q2 2023
      Avg closing price $52.23
      Price range $49.72 - $54.64
      Increased shares by 1.8% (+676k shares) Q1 2023
      Avg closing price $47.13
      Price range $45.09 - $50.03
      Increased shares by 0.0% (+1.55k shares) Q4 2022
      Avg closing price $43.30
      Price range $39.56 - $47.20
      Sold 0.4% shares (-169k shares) Q3 2022
      Avg closing price $40.12
      Price range $36.71 - $43.46
      Sold 0.3% shares (-101k shares) Q2 2022
      Avg closing price $40.71
      Price range $35.24 - $47.10
      Sold 0.5% shares (-198k shares) Q1 2022
      Avg closing price $43.34
      Price range $40.90 - $45.10
      Sold 3.8% shares (-1.49M shares) Q4 2021
      Avg closing price $42.02
      Price range $38.07 - $44.87
      Sold 1.0% shares (-413k shares) Q3 2021
      Avg closing price $44.24
      Price range $41.23 - $45.88
      Sold 2.4% shares (-992k shares) Q2 2021
      Avg closing price $42.07
      Price range $38.58 - $44.24
      Increased shares by 3.9% (+1.55M shares) Q1 2021
      Avg closing price $37.85
      Price range $35.27 - $39.67
      Sold 2.5% shares (-1.02M shares) Q4 2020
      Avg closing price $36.04
      Price range $33.15 - $41.97
      Sold 2.9% shares (-1.2M shares) Q3 2020
      Avg closing price $38.53
      Price range $34.44 - $42.23

      News about Boston Scientific Corp. and PRIMECAP Management

      Mount Lucas Management LP Invests $2.64 Million in Boston Scientific Co. (NYSE:BSX)

      Mount Lucas Management LP Invests $2.64 Million in Boston Scientific Co. (NYSE:BSX)

      ¡­ the SEC. The institutional investor bought 48,868 shares of ¡­ hedge funds and other institutional investors . Wall Street Analysts Forecast ¡­ on the stock....

      EIN News Investing EIN News Investing, almost 2 years ago
      Diamond Hill Capital Management Inc. Decreases Stock Position in Boston Scientific Co. (NYSE:BSX)

      Diamond Hill Capital Management Inc. Decreases Stock Position in Boston Scientific Co. (NYSE:BSX)

      Diamond Hill Capital Management Inc. decreased its position in shares of Boston Scientific Co. (NYSE:BSX ¨C Free Report) by 2.8% in the second quarter, accord...

      The AM Reporter The AM Reporter, almost 2 years ago
      Baldwin Investment Management LLC Buys New Holdings in Boston Scientific Co. (NYSE:BSX)

      Baldwin Investment Management LLC Buys New Holdings in Boston Scientific Co. (NYSE:BSX)

      Baldwin Investment Management LLC purchased a ¡­ $223,000. Other institutional investors and hedge funds also recently ¡­ about $32,000. Institutional investor...

      EIN News Investing EIN News Investing, almost 2 years ago
      Beyond Pills: 3 Non-Pharma Healthcare Stocks for Healthy Gains

      Beyond Pills: 3 Non-Pharma Healthcare Stocks for Healthy Gains

      When you consider healthcare stocks, do you automatically think of pharmaceutical companies? Most people do. However, some of the most significant gains over...

      InvestorPlace InvestorPlace, about 2 years ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×